Dr. Edward E. Rylander, MD

Dr. Rylander practices at Ascension St. John Medical Center in Tulsa, Oklahoma, part of Ascension Health Alliance.

Dr. Rylander's NPI, 1871564930, was assigned on January 27, 2006. Dr. Rylander graduated from Oral Roberts University School of Medicine in 1985. Dr. Rylander holds Oklahoma license 15860.

Dr. Rylander's primary practice is Ascension St. John Medical Center, at 1923 South Utica Avenue, Tulsa, OK 74104 in Tulsa County. The practice phone is (918) 744-2296.

Dr. Rylander's primary practice is Ascension St. John Medical Center in Tulsa, Oklahoma, part of Ascension Health Alliance. Dr. Rylander is also affiliated with Saint Francis Hospital. The medical group on file is Ascension St. John. Dmand AI also links Dr. Rylander to 3 more hospitals, 1 group practice or clinic, 1 home health agency, 1 hospice and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rylander practices, 9 sites in all. Vendor and product names are available with a free account.

Family medicine is Dr. Rylander's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Dr. Rylander is board certified in family medicine by the American Board of Family Medicine. Dr. Rylander is licensed in Oklahoma.

Dmand AI lists acid reflux, acute stomach ulcer, alzheimer's disease, anemia, aneurysm, anxiety, aortic atherosclerois and arthritis among the conditions Dr. Rylander treats.

CMS data shows 965 Medicare services from Dr. Rylander across 11 procedure codes in 2024, for 335 Medicare patients. Medicare paid $54,034 for them.

CMS counts 335 Medicare patients who saw Dr. Rylander in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high blood pressure, and 62% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rylander's median patient age at 65, with 62% women.

In 2024, Dr. Rylander wrote 7,930 Medicare Part D claims for 515 patients. 84% of them were for generic drugs. CMS names the drug for 7,107 of them, across 137 drugs with 11 or more claims each, at $613,877 in total drug cost. In 2023, CMS named 6,452 claims across 127 drugs.

Dr. Rylander accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rylander as offering telehealth.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Rylander to 1 clinical trial. Conditions studied include Hyperlipoproteinemia Type II and Hyperlipoproteinemias.

CMS Open Payments shows 36 general payments to Dr. Rylander from 13 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $114.

Dmand AI lists 1 award for Dr. Rylander, most recently CMS Stage 1 2012 in 2012.

Dr. Rylander graduated from Oral Roberts University School of Medicine in 1985.

Dr. Rylander is in network with 16 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.